DNAJB1 and fibrolamellar hepatocellular carcinoma: Recently, a DNAJB1-PRKACA gene fusion has emerged as the dominant oncogenic event in a rare liver cancer, fibrolamellar carcinoma (FLC; Honeyman et al., 2014).